Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

TFPI resistance related to inherited or acquired protein S deficiency.

Tardy-Poncet B, Piot M, Brunet D, Chapelle C, Bonardel M, Mismetti P, Morange P, Tardy B.

Thromb Res. 2012 Dec;130(6):925-8. doi: 10.1016/j.thromres.2012.07.025. Epub 2012 Oct 15.

PMID:
23079294
2.

Hereditary and acquired protein S deficiencies are associated with low TFPI levels in plasma.

Castoldi E, Simioni P, Tormene D, Rosing J, Hackeng TM.

J Thromb Haemost. 2010 Feb;8(2):294-300. doi: 10.1111/j.1538-7836.2009.03712.x. Epub 2009 Nov 30.

3.

Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels.

Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, Meijers JC, Porte RJ, Lisman T.

Br J Haematol. 2013 Sep;162(6):819-26. doi: 10.1111/bjh.12462. Epub 2013 Jul 11.

PMID:
23841464
4.

Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals.

Maurissen LF, Castoldi E, Simioni P, Rosing J, Hackeng TM.

J Thromb Haemost. 2010 Apr;8(4):750-8. doi: 10.1111/j.1538-7836.2010.03743.x. Epub 2010 Jan 17.

5.

TFPI-dependent activities of protein S.

Peraramelli S, Rosing J, Hackeng TM.

Thromb Res. 2012 May;129 Suppl 2:S23-6. doi: 10.1016/j.thromres.2012.02.024. Epub 2012 Mar 15. Review.

PMID:
22425215
6.

Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.

Dahm A, Rosendaal FR, Andersen TO, Sandset PM.

Br J Haematol. 2006 Feb;132(3):333-8.

PMID:
16409298
7.

Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.

Tchaikovski SN, Thomassen MC, Costa SD, Peeters LL, Rosing J.

Thromb Haemost. 2011 Nov;106(5):914-21. doi: 10.1160/TH11-04-0244. Epub 2011 Oct 6.

PMID:
21979881
8.

Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.

Mukherjee M, Ranlall N, Patel G, Rutlin A, Jehanli A, Kakkar VV.

Blood Coagul Fibrinolysis. 2000 Apr;11(3):285-91.

PMID:
10870809
9.

Increased tissue factor pathway inhibitor activity is associated with myocardial infarction in young women: results from the RATIO study.

Winckers K, Siegerink B, Duckers C, Maurissen LF, Tans G, Castoldi E, Spronk HM, Ten Cate H, Algra A, Hackeng TM, Rosendaal FR.

J Thromb Haemost. 2011 Nov;9(11):2243-50. doi: 10.1111/j.1538-7836.2011.04497.x.

10.

Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden mice.

Tchaikovski SN, van Vlijmen BJ, Cleuren AC, Thomassen MC, Tchaikovski V, Tans G, Rosing J.

J Thromb Haemost. 2009 Feb;7(2):312-8. doi: 10.1111/j.1538-7836.2008.03240.x.

11.

A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).

Dahm AE, Andersen TO, Rosendaal F, Sandset PM.

J Thromb Haemost. 2005 Apr;3(4):651-8.

12.

Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex.

Iversen N, Strekerud FG, Abildgaard U.

Blood Coagul Fibrinolysis. 2000 Oct;11(7):591-8.

PMID:
11085278
13.

The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.

Raps M, Helmerhorst FM, Fleischer K, Dahm AE, Rosendaal FR, Rosing J, Reitsma P, Sandset PM, van Vliet HA.

Thromb Haemost. 2013 Apr;109(4):606-13. doi: 10.1160/TH12-10-0771. Epub 2013 Feb 14.

PMID:
23407778
14.

Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosis.

Tardy-Poncet B, Tardy B, Laporte S, Mismetti P, Amiral J, Piot M, Reynaud J, Campos L, Decousus H.

J Thromb Haemost. 2003 Mar;1(3):507-10.

15.

High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.

Ariëns RA, Moia M, Rivolta E, Ponticelli C, Mannucci PM.

Thromb Haemost. 1999 Sep;82(3):1020-3.

PMID:
10494757
16.

Do antiphospholipid antibodies interfere with tissue factor pathway inhibitor?

Jacobsen EM, Sandset PM, Wisløff F.

Thromb Res. 1999 May 15;94(4):213-20.

PMID:
10336236
17.

Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis.

Oksüzoğlu G, Simsek H, Haznedaroğlu IC, Kirazli S.

Am J Gastroenterol. 1997 Feb;92(2):303-6.

PMID:
9040211
18.

Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives.

Harris GM, Stendt CL, Vollenhoven BJ, Gan TE, Tipping PG.

Am J Hematol. 1999 Mar;60(3):175-80.

19.

Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.

Hirose M, Kimura F, Wang HQ, Takebayashi K, Kobayashi M, Nakanishi K, Akiyama M, Kimura T, Noda Y.

J Thromb Thrombolysis. 2002 Apr;13(2):85-8.

PMID:
12101385
20.

New direct assay of free protein S antigen applied to diagnosis of protein S deficiency.

Aillaud MF, Pouymayou K, Brunet D, Parrot G, Alessi MC, Amiral J, Juhan-Vague I.

Thromb Haemost. 1996 Feb;75(2):283-5.

PMID:
8815577

Supplemental Content

Support Center